COVID-19 Monoclonal Antibody Infusion Administration Code (UB-04 Billing)
Blue Cross and Blue Shield of Kansas (BCBSKS) continues to monitor COVID-19 and the changes with billing new codes. As of May 1,2021, the following new codes will be reimbursed as follows:
| HCPCS Code | Nomenclature | MAP'd like: |
|---|---|---|
| M0245 | INTRAVENOUS INFUSION, BAMLANIVIMAB AND ETESEVIMAB, INCLUDES INFUSION AND POST ADMINISTRATION MONITORING | M0239 M0243 |
If you have any questions regarding this newsletter, please contact your BCBSKS Institutional Relations provider consultant.